Biotechnology Value Fund L P - Significant Ownership

Signature - Title
/s/ Mark N. Lampert - Mark N. Lampert, Authorized Signatory
Location
San Francisco, CA
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Biotechnology Value Fund L P.

Significant Ownership of Biotechnology Value Fund L P

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
MLTX MoonLake Immunotherapeutics Class A ordinary share, par value $0.0001 per share 27.7% $142M 19.8M BVF PARTNERS L P/IL Nov 6, 2025
RPTX Repare Therapeutics Inc. Common Shares, no par value 24% $18.5M 10.3M BVF PARTNERS L P/IL Nov 20, 2025
XOMA XOMA Royalty Corp Common Stock, $0.0075 par value 21.6% $63.7M -$9.66M 2.59M -13.2% BVF GP HOLDINGS LLC May 16, 2025
GHRS GH Research PLC Ordinary Shares, nominal value $0.025 per share 14.2% $79.4M 8.83M BVF PARTNERS L P/IL Mar 31, 2025
KURA Kura Oncology, Inc. Common Stock, par value $0.0001 per share 9.99% $76.8M $24.5M 8.68M +46.8% BVF PARTNERS L P/IL Sep 30, 2025
PVLA PALVELLA THERAPEUTICS, INC. Common Stock, $0.001 par value per share 9.99% $74M 1.18M BVF PARTNERS L P/IL Sep 30, 2025
CBIO CRESCENT BIOPHARMA, INC. Ordinary Shares, $0.001 par value per share 9.99% $18.9M 1.39M BVF PARTNERS L P/IL Jun 30, 2025
AVTX Avalo Therapeutics, Inc. Common Stock, $0.001 par value per share 9.99% $18.5M $5.33M 1.46M +40.4% BVF PARTNERS L P/IL Sep 30, 2025
FDMT 4D Molecular Therapeutics, Inc. Common Stock, par value $0.0001 per share 9.99% $12.3M -$534K 4.63M -4.17% BVF PARTNERS L P/IL Mar 31, 2025
SABS SAB Biotherapeutics, Inc. Common Stock, $0.0001 par value per share 9.99% $10.4M 5.17M BVF PARTNERS L P/IL Sep 30, 2025
IMUX IMMUNIC, INC. Common Stock, $0.0001 par value 9.99% $8.32M 9.79M BVF PARTNERS L P/IL Jun 30, 2025
TCRX TScan Therapeutics, Inc. Voting Common Stock, $0.0001 par value per share 9.99% $6.68M 5.26M BVF PARTNERS L P/IL Mar 31, 2025
UNCY Unicycive Therapeutics, Inc. Common Stock, par value $0.001 per share 9.99% $6.02M 1.42M BVF PARTNERS L P/IL Jun 30, 2025
VTGN Vistagen Therapeutics, Inc. Common Stock, par value $0.001 per share 9.97% $6.35M 3.08M BVF PARTNERS L P/IL Dec 31, 2024
SEPN Septerna, Inc. Common Stock, $0.001 par value per share 9.9% $25.1M 4.4M BVF PARTNERS L P/IL Mar 31, 2025
XFOR X4 Pharmaceuticals, Inc Common Stock, par value $0.001 per share 9.9% $8.8M 2.24M BVF PARTNERS L P/IL Aug 13, 2025
GLUE Monte Rosa Therapeutics, Inc. Common Stock, $0.0001 par value per share 9.2% $23.9M $5.35M 5.66M +28.8% BVF PARTNERS L P/IL Mar 31, 2025
IKNA Ikena Oncology, Inc. Common Stock, par value $0.001 per share 8.3% $4.25M 4.01M BVF PARTNERS L P/IL Dec 31, 2024
TYRA Tyra Biosciences, Inc. Common Stock, $0.0001 par value per share 7.8% $31.4M 3.94M BVF PARTNERS L P/IL Dec 31, 2024
IVVD Invivyd, Inc. Common Stock, $0.0001 par value per share 7.4% $17.6M 16M BVF PARTNERS L P/IL Oct 15, 2025
NEKTAR THERAPEUTICS Common Stock, $0.0001 par value 7.4% 1.28M BVF PARTNERS L P/IL Jul 1, 2025
IMA ImageneBio, Inc. Common Stock, par value $0.001 per share 7.2% $6.42M 802K BVF PARTNERS L P/IL Sep 30, 2025
ELEV Elevation Oncology, Inc. Common Stock, par value $0.0001 per share 7% $1.24M 4.44M BVF PARTNERS L P/IL Mar 31, 2025
XNCR Xencor Inc Common Stock, par value $0.01 per share 6.5% $54.2M 4.62M BVF PARTNERS L P/IL Oct 9, 2025
GPCR Structure Therapeutics Inc. Ordinary Shares, par value $0.0001 per share 5.6% $181M 9.61M BVF PARTNERS L P/IL Aug 11, 2025
ZYME Zymeworks Inc. Common Stock, $0.00001 par value per share 5.2% $67.3M 3.94M BVF PARTNERS L P/IL Sep 30, 2025
CMPX Compass Therapeutics, Inc. Common Stock, $0.0001 par value per share 5.1% $30.6M 8.75M BVF PARTNERS L P/IL Oct 22, 2025
IVA Inventiva S.A. Ordinary Shares, nominal value (euro)0.01 per share 4.99% $39.7M $4.25M 9.57M +12% BVF PARTNERS L P/IL Nov 17, 2025
CDTX Cidara Therapeutics, Inc. Common Stock, par value $0.0001 per share 4.4% $114M -$21.5M 1.19M -15.9% BVF PARTNERS L P/IL Oct 15, 2025
PTGX Protagonist Therapeutics, Inc Common Stock, $0.00001 par value per share 4.1% $170M -$43.2M 2.56M -20.2% BVF PARTNERS L P/IL Sep 30, 2025
VSTM Verastem, Inc. Common Stock, $0.0001 par value per share 3.9% $22.7M -$29.2M 2.5M -56.3% BVF PARTNERS L P/IL Aug 11, 2025
ETNB 89bio, Inc. Common Stock, par value $0.001 per share 3.6% $31.5M 4.33M BVF PARTNERS L P/IL Dec 31, 2024
CTMX CytomX Therapeutics, Inc. Common Stock, $0.00001 par value per share 3.5% $14.4M -$14.4M 5.77M -50% BVF PARTNERS L P/IL Jul 3, 2025
MIRM Mirum Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share 3% $110M 1.5M BVF PARTNERS L P/IL Sep 30, 2025
ENGN enGene Holdings Inc. Common Shares, no par value per share 1.8% $3.78M -$8.42M 945K -69% BVF PARTNERS L P/IL Jan 27, 2025
CELC Celcuity Inc. Common Stock, $0.001 par value per share 1.6% $32.5M 658K BVF PARTNERS L P/IL Sep 30, 2025
NewcelX Ltd. Common Shares, par value CHF 0.05 0.6% 28.7K BVF PARTNERS L P/IL Oct 31, 2025
FBRX Forte Biosciences, Inc. Common Stock, $0.001 par value 0.5% $980K -$8.67M 65.4K -89.8% BVF PARTNERS L P/IL Sep 30, 2025
OVID Ovid Therapeutics Inc. Common Stock, par value $0.001 per share 0% $0 0 BIOTECHNOLOGY VALUE FUND L P Jul 17, 2025
ALLK Allakos Inc. Common Stock, par value $0.001 0% $0 0 BIOTECHNOLOGY VALUE FUND L P May 15, 2025
VIGL Vigil Neuroscience, Inc. Common Stock, par value $0.0001 per share 0% $0 -$38.1M 0 -100% BIOTECHNOLOGY VALUE FUND L P Jun 30, 2025
THRD Third Harmonic Bio, Inc. Common Stock, par value $0.0001 per share 0% $0 0 BIOTECHNOLOGY VALUE FUND L P Apr 14, 2025
VERV Verve Therapeutics, Inc. Common Stock, par value $0.001 per share 0% $0 0 BIOTECHNOLOGY VALUE FUND L P Jun 30, 2025
ITOS iTeos Therapeutics, Inc. Common Stock, $0.001 par value per share 0% $0 -$31.4M 0 -100% BIOTECHNOLOGY VALUE FUND L P Jun 30, 2025
EPIX ESSA Pharma Inc. Common Shares 0% $0 -$2.8M 0 -100% BIOTECHNOLOGY VALUE FUND L P Oct 9, 2025
RAPT RAPT Therapeutics, Inc. Common Stock, $0.0001 par value per share 0% $0 -$303M 0 -100% BIOTECHNOLOGY VALUE FUND L P Sep 30, 2025

Schedules 13D/G Reported by Biotechnology Value Fund L P:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.